Catalyst Pharmaceuticals Inc (CPRX)
21.48
+0.36
(+1.70%)
USD |
NASDAQ |
Nov 22, 16:00
21.47
-0.01
(-0.05%)
After-Hours: 20:00
Catalyst Pharmaceuticals Stock Buybacks (Quarterly): 0.00 for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.00 |
June 30, 2024 | 0.00 |
March 31, 2024 | -140.70M |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 4.356M |
March 31, 2022 | 2.551M |
December 31, 2021 | 3.075M |
September 30, 2021 | 5.053M |
June 30, 2021 | 3.961M |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 |
Date | Value |
---|---|
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | -34.87M |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | -26.73M |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | -14.07M |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | -0.0664M |
September 30, 2012 | -5.56M |
June 30, 2012 | -3.938M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-140.70M
Minimum
Mar 2024
5.053M
Maximum
Sep 2021
-6.762M
Average
--
Median
Jun 2020
Stock Buybacks (Quarterly) Benchmarks
Corcept Therapeutics Inc | 0.00 |
Vertex Pharmaceuticals Inc | 391.40M |
Sarepta Therapeutics Inc | -- |
ADMA Biologics Inc | -- |
BioVie Inc | -2.259M |